Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
about
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesWilms' tumor: biology, diagnosis and treatmentAdvances in Wilms Tumor Treatment and Biology: Progress Through International CollaborationAssociation between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms TumorRace disparities in peptide profiles of North American and Kenyan Wilms tumor specimensGain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.Biomarkers for Wilms Tumor: A Systematic ReviewGenetic and chromosomal alterations in Kenyan Wilms Tumor.MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrencesGenetic variation frequencies in Wilms' tumor: A meta-analysis and systematic reviewIntra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.Biomarkers to detect Wilms tumors in pediatric patients: where are we now?Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group.Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trial
P2860
Q26801785-0E335C96-A57E-4DF0-9B56-1729D51BC670Q26862181-2E772942-F717-4EC3-ADC9-6190D7E19C22Q28083988-84F53C05-91CC-4CEB-8389-5A01435A3592Q28389928-341870E2-8896-4615-8C21-C93657C1D3A7Q30415295-1233C73A-0D5D-42E6-91A7-3E11027CA652Q33893718-71C51B73-94DE-45C7-803B-34D58925DC01Q36040458-6BCAD450-DE4A-4F40-B464-6E650612AC39Q36052678-73C8ADBB-2A22-47AD-BF37-46717DE0C828Q36392072-9383FD34-D1E4-4B17-B76A-1BF53672EC3BQ36611566-96B43A37-6C51-47BC-9BA8-4679880194BCQ36962452-137201C4-B2A3-4FA1-8F8E-42EC0FDD32DBQ37146691-09A0D876-86E9-40D1-8AFC-09FD1F770D61Q37149909-7B521E40-9E78-4284-AC9D-1EE1D83E9CF3Q38559338-B284291E-1C25-4113-B4F0-7003731150D4Q38734260-05D7CB35-DAEF-4F2F-9B40-C3EF04E82D62Q38843141-09B0B6D0-8BA8-468C-A601-732E3873A93CQ38972223-1129B951-6463-440D-8A7C-16205B4513E1Q38998052-0675223B-76CA-40EF-A215-E6EF2729119CQ41520220-0AFCEB89-FA4E-4E5D-951C-3F403D84209EQ47797328-48C1E926-5238-4FC1-975F-E478658A0E47Q52586258-54FA3835-C4A2-40E4-885A-B1B2FED2F236Q57339469-FB7BBBB2-5270-4E5E-859C-7DBEE1EF9BAE
P2860
Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Gain of 1q is associated with ...... the Children's Oncology Group.
@ast
Gain of 1q is associated with ...... the Children's Oncology Group.
@en
type
label
Gain of 1q is associated with ...... the Children's Oncology Group.
@ast
Gain of 1q is associated with ...... the Children's Oncology Group.
@en
prefLabel
Gain of 1q is associated with ...... the Children's Oncology Group.
@ast
Gain of 1q is associated with ...... the Children's Oncology Group.
@en
P2093
P2860
P356
P1433
P1476
Gain of 1q is associated with ...... the Children's Oncology Group.
@en
P2093
Elizabeth J Perlman
Eric J Gratias
James R Anderson
Jeffrey S Dome
Lawrence J Jennings
Paul Grundy
P2860
P304
P356
10.1002/CNCR.28239
P407
P577
2013-08-26T00:00:00Z